John Matthew Maris, M.D.

  • Department: Pediatrics
  • Division: Oncology
  • Email: MARIS@CHOP.EDU
  • Primary Address:
    The Children's Hospital of Philadelphia
    Division of Oncology
    Abramson Research Center 907A
    3615 Civic Center Boulevard

    4399
    Philadelphia, PA 19104
  • 215 590 5244

    Expertise

    Dr. Maris's research focuses on translational genomics and genetics of neuroblastoma.

    Appointments

    Professor of Pediatrics, University of Pennsylvania School of Medicine (2010 – present)
    Associate Professor of Pediatrics, University of Pennsylvania School of Medicine (2004 – 2010)
    Assistant Professor of Pediatrics, University of Pennsylvania School of Medicine (1996 – 2004)

    Education

    M.D., Medicine, University of Pennsylvania (1989)
    B.S., Biology, Wheeling College (1983)

    Selected Publications

    Wang Q, Guo C, Hii G, Shusterman S, Mosse Y, Zhao H, Cnaan A, Rappaport E, Hogarty MD and Maris JM. ID2 expression is not correlated with MYCN gene amplification or expression in human neuroblastomas. Cancer Research. Vol 63. 2003:1631-1635.
    Maris JM and Castleberry RP. Chemotherapy for Neuroblastoma: Is It All or None?. Journal of Pediatric Hematology/Oncology. Vol 25. 2003:512-514.
    Shusterman S, King RL, Rappaport E, Barr R, and Maris JM. Discovery of antiangiogenic targets induced by chemotherapy in a murine model of human neuroblastoma. Proceedings of the 94th Annual Meeting of the American Association for Cancer Research. Vol 44(2nd Ed) . 2003.
    Mosse Y, Greshock J, Khazi, D, Hii, G., Wang Q, Morowitz MJ, Winter C, Shusterman S, Weber BL, and Maris JM. Functional genomic analysis of neuroblastoma for high resolution mapping of 11q deletions. Proceedings of the 94th Annual Meeting of the American Association for Cancer Research. Vol 44(2nd Ed) . 2003:1214 (#6077).
    Maris JM. Molecular Genetic Staging of Human Neuroblastoma. ASCO Education Book. 2003:353-362.
    Maris JM and Shusterman S.. Neuroblastoma. Cancer Medicine, 6th Edition. BC Decker, Lewiston, NY; 2003:2263-2376.
    Fang J, Stern JW, Shusterman S, Alcorn K, Pierson G, Barr R, Pawel B, Diller L, Maris JM, and Grupp SA. Transplantation in Hematology and Oncology II. Springer-Verlag Berlin Heidelberg; 2003:283-298.
    Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS, Hogarty MD, Mirensky T, Brodeur GM, Rebbeck TR, Urbanek M, and Shusterman S. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Research. Vol 62. 2002:6651-6658.
    Hogarty MD, Winter CL, Liu X, Guo C, White PS, Look AT, Brodeur GM, and Maris JM. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome subband 1p36.3. Cancer Research. Vol 62. 2002:6481-6484.
    Houghton PJ, Adamson PC, Blaney S, Fine H, Gorlick R, Haber M, Helman L, Hirschfeld S, Hollingshead MG, Israel MA, Lock RB, Maris JM, Merlino G, Patterson W, Reynolds P, Shannon K, Yu A, Yu J, and Smith MA. Testing of new agents in pediatric cancer preclinical models. Clinical Cancer Research. Vol 8. 2002:3646-3657.